Advanced Medicine

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Could zinc finger therapy hold the key to treating Alzheimer’s disease?

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"